Clinical trial
A Stratified, Post-Market Study of DeNovo NT for the Treatment of Femoral and Patellar Articular Cartilage Lesions of the Knee
NCT01670617 is registered in ClinicalTrials.gov with Zimmer Orthobiologics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Stratified, Post-Market Study of DeNovo NT for the Treatment of Femoral and Patellar Articular Cartilage Lesions of the Knee
- Lead sponsor
- Zimmer Orthobiologics, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2012
- Completion date
- December 31, 2021
- Enrollment
- 90 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
defect of articular cartilage, knee injuries